Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Enigmatig (NYSE American:EGG) Stock Swings Again With No Clear Reason in Sight

● Enigmatig shares have climbed to $3.28, up 7.54%, on only about 26,100 shares changing hands, a modest turnover that underscores how little trading it can take to move this thinly followed stock.

Nitish Kishor | 25 August 2026

Evolution Metals & Technologies (NASDAQ:EMAT) Stock Rises on Real Volume in the Rare-Earth Reshoring Trade

● Evolution Metals & Technologies shares have risen to $4.21, up 6.05%, on genuinely active trading of about 2.97 million shares and elevated relativeVolumeof 2.43.

Nitish Kishor | 25 August 2026

Entera Bio (NASDAQ:ENTX) Stock Climbs on Thin Volume as Its Oral Peptide Platform Advances

● Entera Bio shares have climbed to $3.42, up 5.88%, onVolumeof about 258,000 shares and relative volume of just 0.60, below the stock's own average.

Nitish Kishor | 25 August 2026

BellRing Brands (NYSE:BRBR) Stock Rises as Investors Reassess the Protein-Nutrition Growth Story

● BellRing Brands shares have risen 6.48%, extending a volatile year for one of the most closely watched names in the fast-growing convenient-nutrition category.

Nitish Kishor | 25 August 2026

BRC (NYSE:BRCC) Stock Rises Days After a Reverse Split as Black Rifle Coffee Nears Profitability

● BRC shares have risen to $9.33, up 6.03%, onVolumeof roughly 503,700 shares, about 3.8 times the stock's recent average, in only its second full session trading on a split-adjusted basis.

Nitish Kishor | 25 August 2026

Cango (NYSE:CANG) Stock Rises as Its Bitcoin Mining Pivot Tracks Crypto Sentiment

● Cango shares have risen to $2.30, up 7.48%, onVolumeof about 1.69 million shares, roughly 2.9 times its recent average.

Nitish Kishor | 25 August 2026

Capricor Therapeutics (NASDAQ:CAPR) Stock Jumps as the FDA Extends Its Review Instead of Rejecting

● Capricor Therapeutics shares have risen to about $6.80, up 8.11%, on heavyVolumeof roughly 20.1 million shares, a high-participation move tied to a concrete catalyst.

Nitish Kishor | 25 August 2026

Alto Neuroscience (NYSE:ANRO) Stock Extends a Re-Rating on a Deep Cash Cushion

● Alto Neuroscience shares have risen to $36.25, up 5.75%, onVolumeof about 868,000 shares and relative volume of 1.73, pointing to real institutional interest.

Nitish Kishor | 25 August 2026

Arcturus Therapeutics (NASDAQ:ARCT) Stock Climbs After Reclaiming Full Rights to Its COVID Vaccine

● Arcturus Therapeutics shares have climbed to $14.34, up 6.62%, onVolumeof roughly 2.41 million shares, a touch above its recent norm.

Nitish Kishor | 25 August 2026

CBL International (NASDAQ:BANL) Stock Climbs on Thin Volume Into a Special Dividend Record Date

● CBL International shares have climbed to about $13.69, up 8.22%, on remarkably thin trading of roughly 52,300 shares, a fraction of the stock's normal activity.

Nitish Kishor | 25 August 2026
Support

Hi! How can we help you today?

Loading…